CEB-01

DRUG2 trials

Sponsors

CEBIOTEX

Conditions

Locally Resectable Pediatrics TumorsPancreatic Carcinoma

Early Phase 1

CEB-01 in Locally Resectable Pancreatic Cancer

Active, not recruitingNCT06538857

CEBIOTEXPancreatic Carcinoma

Start: 2024-08-20End: 2028-09-01Target: 39Updated: 2026-10-14

Phase 2

CEB-01 in Pediatrics With Locally Resectable Abdominal Tumors

Active, not recruitingNCT06986811

CEBIOTEXLocally Resectable Pediatrics Tumors

Start: 2025-05-06End: 2029-05-01Target: 80Updated: 2026-10-20